NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Durham-based Avista Pharma Solutions has been tapped by a Minneapolis research organization to manufacture an important component of a vaccine to combat opioid addiction.

Privately owned life science companies looking for funding still have a few days to apply for a chance to pitch their stories to potential investors and partners at the 2017 SEBIO Investor and Partnering Forum in Pinehurst this fall.

For more than 30 years, Genova Diagnostics has been quietly growing its clinical laboratory services from its headquarters in Asheville, evolving into the significant new world of precision health services.

Innovate Biopharmaceuticals, a clinical-stage biotechnology company based in Raleigh, has submitted an application to the U.S. Food and Drug Administration (FDA) seeking orphan drug designation for an oral therapy to treat pediatric ulcerative colitis.

Durham-based Viamet Pharmaceuticals has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its anti-fungal agent VT-1598, a novel oral therapy for the treatment of valley fever.

Already a major landlord in the Research Triangle Park, California-based Alexandria Real Estate Equities is developing a unique multi-tenant research and development campus in the Research Triangle Park to drive North Carolina’s global leadership in agricultural biotechnology.

A series of new reports by the Pharmaceutical Research and Manufacturers of America (PhRMA) highlight North Carolina’s position as a top state in the nation for driving innovation and economic growth for the 21st Century through efforts to attract and grow the biopharmaceutical industry amid an increasingly competitive global environment.

A cell-based therapy developed in Durham for a rare liver disease in newborns has been accepted for regulatory review in Canada.

Raleigh-based Innovate Biopharmaceuticals may become a publicly traded company soon following an agreement to merge with a California company already listed on the NASDAQ stock exchange.

Panaceutics, a personalized medicine and clinical nutrition company in Research Triangle Park, will partner with Florida Hospital’s Cardiovascular Institute on a new way to help patients with heart disease take all of their medicines as prescribed.

Panaceutics, a personalized medicine and clinical nutrition company in Research Triangle Park, will partner with Florida Hospital’s Cardiovascular Institute (CVI) on a new way to help patients with heart disease take all of their medicines as prescribed.

NCEast Alliance, a Greenville-based economic development organization serving 28 counties with about 1.3 million residents in eastern North Carolina, will receive $100,000 from the state to help develop the region’s growing life science sector.

First Flight Venture Center has set a date of September 13, 2017 to roll back the doors of Hangar6, calling it “an advanced rapid prototyping facility.”

A sow and a soybean walk into a lab.

It might be the start of a good joke. I don’t know. But Tim Xtreme Lee has done the due diligence to extract the funny from the corn.  

The billion-dollar cell culture Seqirus vaccine factory in Holly Springs has hit yet another milestone. The highly skilled workers at the sprawling factory southeast of Raleigh successfully produced the world’s first cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.

Durham-based Innocrin Pharmaceuticals, a clinical-stage company focused on developing new cancer treatments, has received a regulatory boost for its work in Europe.